Skip to main content
. 2013 Feb 13;8(2):e56169. doi: 10.1371/journal.pone.0056169

Table 2. The characteristics of the patients included in the study.

Sex Female 100%
Age 26–97 Average 55,67
Grade 1 13,6% (n = 36)
2 36,3% (n = 96)
3 32,2% (n = 85)
Nd 17,8% (n = 47)
Stage IA 1%
IB 60%
IIA 20%
IIB 18%
III 1%
Treatment Radiotherapy (50 Gy) + brachytherapy (15 Gy) + cisplatin (6 cycles: 40 mg/m2)